Wednesday, August 10, 2011

Grandhope Successfully Launched IPO Initial Public Offerings

Guangzhou China, August 9, 2011CCM has released the latest issue of Industrial Biotechnology China News on July 7, 2011, with the top news that Grandhope Biotech Co., Ltd. (Grandhope) launched Initial Public Offerings (IPO) in Shenzhen Growth Enterprise Market (GEM)
Grandhope's successful listing, which will break the foreign enterprises' monopoly in the medical device industry, depends on its technology and insight of the medical device industry market. The improved technology makes its products full of high stability, low immunogenicity and tissue regeneration inducement, which had their own advantages in the industry competition.

The company plans to invest about USD38 million in the construction of national regenerative medical implants engineering laboratory, high-tech industrialization of sterile biological membrane, market expansion and maintenance of the core business. Grandhope is optimistic about its products' future prospects in domestic medical device market, especially in meningeal medical market.

What’s more, this issue focuses on the chemical fiber in China. Many China's enterprises, such as Baosteel and Shandong Jingdian, strive to develop biofuel industry in order to occupy good position in new energy area. Aiming at the biology industry, this issue also focuses on not only the biobased chemical of the SA program and L-tryptophan expansion in China, but also bioproduct such as Angel Yeast's project and domestic hemicellulase investment.

More highlights are covered in the latest issue of Industrial Biotechnology China News:
-Shandong Jingdian plans to industrially produce glycerin-based PG in 2012.-Baosteel is making efforts to promote  industrialization of carbon monoxide-based fuel ethanol.-Celanese may begin industrial ethanol production in China in 2013.                                                                                                -China's export volume of butanol increased, while its import volume decreased.                                                                                                                        -Angel Yeast is going to accelerate its expansion of yeast capacity.                                                                                                               -Hemicellulase has been attracting more and more investment in China.                                                                                                   -CAS plans to accelerate the commercial production of sialic acid (SA) by fermentation method in the future.-Some domestic L-tryptophan producers are actively promoting expansion.-Changjiang Chemical Fiber successfully completed the trial production of PLA fiber.                                                                        -RSPC invested in a new plan by its raised fund for a PTT production line with capacity of  90,000t/a.
-Three polyvinyl alcohol (PVA) production lines of Wanwei Updated High-tech Material Industry Co., Ltd.  (Wanwei Updated High-tech) will be launched in 2011-2012.                                                                                                                                                                       -China's PLA import volume significantly rose in H1 2011 year on year.                                                                                       -Grandhope launched Initial Public Offerings (IPO) in Shenzhen Growth Enterprise Market (GEM).

About CCM

CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals. CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis all through its new proprietary product ValoTracer.
Please visit for more information or contact

CCM International Ltd.
Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China

No comments: